Pyxis Oncology, Inc.PYXSNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-16.8%
5Y CAGR+41.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-16.8%/yr
Annual compound
5Y CAGR
+41.1%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
5.6x
Strong expansion
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.51M | -15.4% |
| 2024 | $25.42M | -22.0% |
| 2023 | $32.61M | -12.7% |
| 2022 | $37.35M | +100.1% |
| 2021 | $18.66M | +385.3% |
| 2020 | $3.85M | +132.4% |
| 2019 | $1.66M | - |